Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge for the design and development of AnemoCheck Mobile, a non-invasive, handheld, digital technologies to detect and diagnose sickle cell disease (SCD), malaria, and anemia.

Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge for the design and development of AnemoCheck Mobile, a non-invasive, handheld, digital technologies to detect and diagnose sickle cell disease (SCD), malaria, and anemia.

AnemoCheck Mobile has the potential to be combined with key assessments for evaluation of malaria and sickle cell disease for populations who need it most.

Continue Reading Sanguina wins 3rd prize in the NIH Technology Accelerator Challenge for the design and development of AnemoCheck Mobile, a non-invasive, handheld, digital technologies to detect and diagnose sickle cell disease (SCD), malaria, and anemia.
Sanguina collaborators publish new findings on utility of AnemoCheck-LRS, a test designed for low resource settings and severe anemia cases

Sanguina collaborators publish new findings on utility of AnemoCheck-LRS, a test designed for low resource settings and severe anemia cases

AnemoCheck-LRS is being designed for low resource settings where anemia is the most severe. In this publication, collaborators conducted 570 evaluations and concluded that AnemoCheck-LRS is a rapid, inexpensive, and…

Continue Reading Sanguina collaborators publish new findings on utility of AnemoCheck-LRS, a test designed for low resource settings and severe anemia cases